Welcome to LookChem.com Sign In|Join Free

CAS

  • or

76706-67-7

Post Buying Request

76706-67-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

76706-67-7 Usage

Description

4-Thiazolecarboxylicacid,2-ethyl-,ethylester(9CI) is a thiazolecarboxylic acid derivative featuring a thiazole ring and a carboxylic acid group, with an ethyl and ethyl ester substituent. 4-Thiazolecarboxylicacid,2-ethyl-,ethylester(9CI) is recognized for its versatile reactivity and potential to form bioactive molecules, making it a significant intermediate in organic synthesis and a promising candidate in medicinal chemistry.

Uses

Used in Pharmaceutical Synthesis:
4-Thiazolecarboxylicacid,2-ethyl-,ethylester(9CI) is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity allow it to be incorporated into the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Production:
4-Thiazolecarboxylicacid,2-ethyl-,ethylester(9CI) also serves as an important intermediate in the production of agrochemicals. Its potential to form bioactive molecules makes it valuable in the creation of pesticides, herbicides, and other agricultural products designed to protect crops and enhance agricultural yields.
Used in Antibacterial and Antifungal Applications:
4-Thiazolecarboxylicacid,2-ethyl-,ethylester(9CI) has been studied for its potential antibacterial and antifungal properties. Its ability to combat microbial infections positions it as a candidate for use in the development of new antimicrobial agents, addressing the growing need for effective treatments against drug-resistant pathogens.
Used in Organic Synthesis Reactions:
Due to its ethyl ester form, 4-Thiazolecarboxylicacid,2-ethyl-,ethylester(9CI) can be easily integrated into various organic synthesis reactions. This makes it an important building block for the production of other organic compounds, further expanding its applications across different industries.

Check Digit Verification of cas no

The CAS Registry Mumber 76706-67-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,7,0 and 6 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 76706-67:
(7*7)+(6*6)+(5*7)+(4*0)+(3*6)+(2*6)+(1*7)=157
157 % 10 = 7
So 76706-67-7 is a valid CAS Registry Number.

76706-67-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-ethyl-1,3-thiazole-4-carboxylate

1.2 Other means of identification

Product number -
Other names ethyl 2-ethylthiazole-4-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:76706-67-7 SDS

76706-67-7Relevant articles and documents

Copper(II)-catalyzed oxidation of 4-carboxythiazolines and 4-carboxyoxazolines to 4-carboxythiazoles and 4-carboxyoxazoles

Wang, Yiyun,Li, Ziyuan,Huang, Yue,Tang, Changhua,Wu, Xiaoming,Xu, Jinyi,Yao, Hequan

supporting information; experimental part, p. 7406 - 7411 (2011/10/09)

A mild copper(II)-catalyzed oxidation of 4-carboxythiazolines and 4-carboxyoxazolines to 4-carboxythiazoles and 4-carboxyoxazoles has been developed. Various substrates with alkyl or aryl substitutions at 2-position on azoline ring could be smoothly oxidi

PHENOXYPYRIDINYLAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PDE4 MEDIATED DISEASE STATES

-

Page/Page column 132-133, (2009/12/27)

The present invention provides a compound of a formula (I), wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.

(+)-Cystothiazole G: Isolation and structural elucidation

Akita, Hiroyuki,Sasaki, Takamitsu,Kato, Keisuke,Suzuki, Yoshihiro,Kondo, Keiko,Sakagami, Youji,Ojika, Makoto,Fudou, Ryosuke,Yamanaka, Shigeru

, p. 4735 - 4738 (2007/10/03)

Palladium-catalyzed cyclization-methoxycarbonylation of (2R,3S)-3-methylpent-4-yne-1,2-diol (6) derived from (2R,3S)-epoxybutanoate 5 followed by methylation gave the tetrahydro-2-furylidene acetate (-)-7, which was converted to the left-half aldehyde (+)-3. A Wittig reaction between (+)-3 and the phosphoranylide derived from the bithiazole-type phosphonium iodide 4 using lithium bis(trimethylsilyl)amide afforded the (+)-cystothiazole G (2), whose spectral data were identical with those of the natural product (+)-2. Thus, the stereochemistry of cystothiazole G (2) was proved to be (4R,5S,6(E)).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 76706-67-7